Icade Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Icade has a total shareholder equity of €4.5B and total debt of €4.7B, which brings its debt-to-equity ratio to 104.6%. Its total assets and total liabilities are €10.8B and €6.3B respectively. Icade's EBIT is €162.2M making its interest coverage ratio -10.1. It has cash and short-term investments of €1.2B.

Belangrijke informatie

104.6%

Verhouding schuld/eigen vermogen

€4.71b

Schuld

Rente dekkingsratio-10.1x
Contant€1.15b
Aandelen€4.50b
Totaal verplichtingen€6.32b
Totaal activa€10.82b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

A Look At Icade's (EPA:ICAD) Share Price Returns

Feb 23
A Look At Icade's (EPA:ICAD) Share Price Returns

How Did Icade SA's (EPA:ICAD) 8.0% ROE Fare Against The Industry?

Jan 19
How Did Icade SA's (EPA:ICAD) 8.0% ROE Fare Against The Industry?

What Type Of Shareholders Make Up Icade SA's (EPA:ICAD) Share Registry?

Dec 13
What Type Of Shareholders Make Up Icade SA's (EPA:ICAD) Share Registry?

Analyse van de financiële positie

Kortlopende schulden: ICAD's short term assets (€4.1B) exceed its short term liabilities (€2.0B).

Langlopende schulden: ICAD's short term assets (€4.1B) do not cover its long term liabilities (€4.3B).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: ICAD's net debt to equity ratio (79%) is considered high.

Schuld verminderen: ICAD's debt to equity ratio has reduced from 178.8% to 104.6% over the past 5 years.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: Whilst unprofitable ICAD has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Voorspelling contante baan: ICAD is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 46.5% per year.


Ontdek gezonde bedrijven